Iganidipine, a New Water-Soluble Ca²⁺Antagonist: Ocular and Periocular Penetration after Instillation

• Kiyoshi Ishii

  From the Eye Clinic, Omiya Red Cross Hospital, Omiya, Japan; the

• Hiroshi Matsuo

  Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan; the

• Yasuhiro Fukaya

  Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan; the

• Sumiyoshi Tanaka

  Department of Ophthalmology, University of Teikyo School of Medicine, Tokyo, Japan; and the

• Hideyuki Sakaki

  Research Laboratory for Drug Development, Senju Pharmaceutical Co., Ltd., Kobe, Japan.

• Mitsunori Waki

  Research Laboratory for Drug Development, Senju Pharmaceutical Co., Ltd., Kobe, Japan.

• Makoto Araie

  Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan; the

Journal

• Investigative Opthalmology & Visual Science

  Investigative Opthalmology & Visual Science 44 (3), 1169-, 2003-03-01

  Association for Research in Vision and Ophthalmology (ARVO)

Details

• CRID: 1361418521448286976
• NII Article ID: 30004435513
• DOI: 10.1167/iovs.02-0482
• ISSN: 15525783
• Web Site: http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.02-0482
• Data Source:
  • Crossref
  • CiNii Articles